Results 101 to 110 of about 68,845 (338)

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews, Arron Lacey, Kate Bache, Emma J. Kidd   +3 more
wiley   +1 more source

Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials [PDF]

, 2001
BACKGROUND: Hormone replacement therapy (HRT) is often seen as the treatment of choice for preventing fractures in women. We undertook a recent meta-analysis of randomised trials which suggested that HRT reduced non-vertebral fractures by 30%.
Bell-Syer, Sally E.M., Torgerson, David J.   +1 more
core   +3 more sources

Associations of plasma sex‐related hormone and protein levels and alcohol dependence

Addiction, EarlyView.
Abstract Background and Aims Sex‐related hormones and proteins may underlie sex differences in alcohol use disorder characteristics and consequences. Previous reports suggest steroid sex hormones may influence alcohol consumption behaviors while proteins that regulate their circulation levels are rarely investigated.
Ada Man‐Choi Ho, Jennifer R. Geske, Vanessa K. Pazdernik, T. Cameron Waller, Anthony Batzler, Stacey J. Winham, Victor M. Karpyak   +6 more
wiley   +1 more source

Prevalence and Risk Factors of Post‐Extraction Complications in a Western Australian Tertiary Dental Hospital: A Retrospective Cross‐Sectional Study

Australian Dental Journal, EarlyView.
ABSTRACT Objectives Dental extractions are routine procedures, yet they carry a risk of post‐operative complications that can negatively affect patients' quality of life. This study aimed to identify patient‐, tooth‐ and clinician‐related risk factors associated with post‐extraction complications at Western Australia's only tertiary dental hospital, to
Peter Dignam, Mariam Elshafey, Aparna Jeganathan, Magdalen Foo, Joon Soo Park, Manorika Ratnaweera   +5 more
wiley   +1 more source

Progestins and endometrial cancer

Gynecological Endocrinology, 2001
Premenopausal women--especially young women--with endometrial cancer stage I may be treated successfully with progestins alone as primary therapy to preserve their child-bearing potential. There is some indication that progestins could be used in neoadjuvant fashion.
openaire   +3 more sources

Evaluation of dimethandrolone undecanoate in non‐human primates as a candidate for long‐acting injectable male contraceptive

Andrology, EarlyView.
Abstract Background Dimethandrolone undecanoate (DMAU) is under development as a single agent hormonal male contraceptive. DMAU is a prodrug hydrolyzed by esterase(s) to the active metabolite dimethandrolone (DMA) which has dual androgenic and progestogenic actions.
Deborah I. Bunin, Kyuri Kim, Toufan Parman, Janet Gahagen, Mary B. Zelinski, Tiffany Adevai, Christina Wang, Liang Tang, Lalitha Iyer, Aaron Endsley, Diana L. Blithe, Min S. Lee   +11 more
wiley   +1 more source

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Epidemiologic Reviews, 2014
To assess the joint relationships among body mass index, menopausal status, and breast cancer according to breast cancer subtype and estrogen-progestin medication use, we conducted a meta-analysis of 89 epidemiologic reports published in English during ...
M. Munsell, B. Sprague, D. Berry, G. Chisholm, A. Trentham-Dietz   +4 more
semanticscholar   +1 more source

Luteinizing hormone receptor knockout mouse: What has it taught us?

Andrology, EarlyView.
Abstract Luteinizing hormone (LH), along with its agonist choriongonadotropin (hCG) in humans, is the key hormone responsible for the tropic regulation of the gonadal function. LH and hCG act through their cognate receptor, the luteinizing hormone/choriongonadotropin receptor (LHCGR; more appropriately LHR in rodents lacking CG), located in the testis ...
Ilpo T. Huhtaniemi
wiley   +1 more source

BEBERAPA FAKTOR YANG BERKAITAN DENGAN PEMILIHAN TYPE ALAT KONTRSEPSI SUNTIK PADA IBU MENYUSUI DI KECAMATAN GENUK,BULAN JUNI 2003 [PDF]

, 2003
Penelitian yang dilakukan oleh Sindhung (1999) menyebutkan bahwa faktor-faktor yang mempengaruhi penggunaan alat kontrasepsi diantaranya adalah Pengetahuan, Informasi, umur, Sosial ekonomi serta dukungan tohok masyarakat / keluarga. Hal ini sesuai dengan
PRIHATMIATI K , ATIEK
core  

Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients [PDF]

, 1993
Glucocorticoid hormones suppress the secretion of ACTH evoked by secretagogues such as CRF and arginine vasopressin. In this study, we investigated the effects of glucocorticoids on ACTH release induced by oxytocin (OT) and on intracellular free calcium ...
Dayanithi, G., Gratzl, Manfred, Link, H.
core   +1 more source